--- title: "FocalTherics (NASDAQ:FOCL) Receives Average Rating of \"Hold\" from Brokerages" type: "News" locale: "en" url: "https://longbridge.com/en/news/295946793.md" description: "FocalTherics (NASDAQ:FOCL) holds a consensus 'Hold' rating from five covering analysts, with an average 12-month price target of $9.00. Recent updates include Mizuho's 'outperform' at $15.00, Piper Sandler's 'neutral', Wall Street Zen's 'hold', and HC Wainwright's 'buy' at $10.00. The stock traded at $4.64 on Friday. Institutional investors hold 62.74% of shares, with several firms adjusting positions in recent quarters." datetime: "2026-08-14T14:14:17.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/295946793.md) - [en](https://longbridge.com/en/news/295946793.md) - [zh-HK](https://longbridge.com/zh-HK/news/295946793.md) generator: "portal-rs" --- # FocalTherics (NASDAQ:FOCL) Receives Average Rating of "Hold" from Brokerages FocalTherics (NASDAQ:FOCL - Get Free Report) has been assigned a consensus rating of "Hold" from the five research firms that are covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation, one has issued a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month target price among brokerages that have updated their coverage on the stock in the last year is $9.00. FOCL has been the topic of several analyst reports. Mizuho set a $15.00 price objective on FocalTherics and gave the company an "outperform" rating in a research report on Friday, July 17th. Piper Sandler reissued a "neutral" rating on shares of FocalTherics in a report on Friday. Wall Street Zen raised FocalTherics to a "hold" rating in a report on Saturday, August 1st. Finally, HC Wainwright reaffirmed a "buy" rating and set a $10.00 price objective on shares of FocalTherics in a research report on Tuesday, June 2nd. **Check Out Our Latest Research Report on FocalTherics** ## FocalTherics Price Performance FOCL stock traded up $0.01 during trading on Friday, hitting $4.64. 1,495 shares of the stock traded hands, compared to its average volume of 62,962. The company has a current ratio of 1.34, a quick ratio of 0.99 and a debt-to-equity ratio of 1.79. The stock has a market capitalization of $173.91 million, a PE ratio of -5.73 and a beta of -0.04. FocalTherics has a 1 year low of $1.30 and a 1 year high of $6.40. The stock has a 50 day simple moving average of $5.38. ## Institutional Inflows and Outflows A number of hedge funds and other institutional investors have recently added to or reduced their stakes in FOCL. SmartHarvest Portfolios LLC bought a new stake in FocalTherics in the 1st quarter worth approximately $38,000. Lido Advisors LLC purchased a new position in shares of FocalTherics in the 1st quarter worth $40,000. Kovack Advisors Inc. bought a new stake in shares of FocalTherics in the fourth quarter worth $53,000. Rock Springs Capital Management LP increased its position in FocalTherics by 1.3% during the fourth quarter. Rock Springs Capital Management LP now owns 1,286,500 shares of the company's stock valued at $4,233,000 after acquiring an additional 16,500 shares during the last quarter. Finally, Leonteq Securities AG purchased a new stake in FocalTherics during the fourth quarter valued at $313,000. Institutional investors own 62.74% of the company's stock. ## About FocalTherics (Get Free Report) EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST). The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. ## Featured Stories - Five stocks we like better than FocalTherics - Joint Operations: Curaleaf Makes a Play for Aurora Cannabis - Cerebras Sells Off After Earnings: Is This a Market Disconnection? - Is Lockheed Martin Gearing Up to Lead Defense Stocks? - Inside Teledyne's Bold Bet on the Future of Medical Imaging *This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.* Continue following MarketBeat Add MarketBeat as your preferred source on Google to see our latest stories in your feed. Add As Preferred Source ## Should You Invest $1,000 in FocalTherics Right Now? Before you consider FocalTherics, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and FocalTherics wasn't on the list. While FocalTherics currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks Here ### Related Stocks - [FOCL.US](https://longbridge.com/en/quote/FOCL.US.md) - [MFG.US](https://longbridge.com/en/quote/MFG.US.md) - [8411.JP](https://longbridge.com/en/quote/8411.JP.md) - [PIPR.US](https://longbridge.com/en/quote/PIPR.US.md) - [CURLF.US](https://longbridge.com/en/quote/CURLF.US.md) - [ACB.US](https://longbridge.com/en/quote/ACB.US.md) - [CBRS.US](https://longbridge.com/en/quote/CBRS.US.md) - [LMT.US](https://longbridge.com/en/quote/LMT.US.md) - [TDY.US](https://longbridge.com/en/quote/TDY.US.md) ## Related News & Research - [FocalTherics (FOCL) Projected to Announce Quarterly Earnings on Thursday](https://longbridge.com/en/news/296439678.md) - [Edap TMS CFO Kenneth S. Mobeck buys 5,000 common shares for $23,750](https://longbridge.com/en/news/296088848.md) - [FocalTherics™ Reports Second Quarter 2026 Financial Results | FOCL Stock News](https://longbridge.com/en/news/295838933.md) - [VSE (NASDAQ:VSEC) CEO John Cuomo Sells 17,500 Shares of Stock](https://longbridge.com/en/news/296401611.md) - [Simpar unit CS Infra buys Terra’s 49% stake in CS Mobi Leste SP](https://longbridge.com/en/news/296285820.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**